NCT05628883 2026-04-02Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed17 enrolled